1-5 of 5
Weiliang Shi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes for Initial Patient Cohorts with up to 33 Months of Follow-up in the Hgb-206 Phase 1 Trial

Julie Kanter, MD, John F. Tisdale, MD, Janet L. Kwiatkowski, MD, Lakshmanan Krishnamurti, MD, Markus Y. Mapara, MD PhD, Manfred Schmidt, PhD, Alexandra L. Miller, Francis J. Pierciey, Jr., Weiliang Shi, PhD, Jean-Antoine Ribeil, MD PhD, Mark C. Walters, MD, Alexis A. Thompson, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 1080.
https://doi.org/10.1182/blood-2018-99-113477
Published: 2018
Journal Articles

Current Results of Lentiglobin Gene Therapy in Patients with Severe Sickle Cell Disease Treated Under a Refined Protocol in the Phase 1 Hgb-206 Study

John F. Tisdale, MD, Julie Kanter, MD, Markus Y. Mapara, MD PhD, Janet L. Kwiatkowski, MD, Lakshmanan Krishnamurti, MD, Manfred Schmidt, PhD, Alexandra L. Miller, Francis J. Pierciey, Jr., Weiliang Shi, PhD, Jean-Antoine Ribeil, MD PhD, Mohammed Asmal, MD PhD, Alexis A. Thompson, MD MPH, Mark C. Walters, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1026.
https://doi.org/10.1182/blood-2018-99-113480
Published: 2018
Journal Articles

Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence

Clark Paramore, MPH, Amanda Kong, MPH, Sachiyo Minegishi, Weiliang Shi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4811.
https://doi.org/10.1182/blood-2018-99-118874
Published: 2018
Journal Articles

Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

Julie Kanter, MD, Mark C. Walters, MD, Matthew Hsieh, MD, Lakshmanan Krishnamurti, MD, Janet L. Kwiatkowski, MD, Rammurti Kamble, MD, Christof von Kalle, MD, Marcelyne Joseney-Antoine, Francis J. Pierciey, Jr., Weiliang Shi, PhD, Mohammed Asmal, MD PhD, Alexis A Thompson, MD MPH, John F Tisdale, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 527.
https://doi.org/10.1182/blood.V130.Suppl_1.527.527
Published: 2017
Journal Articles

Dynamo: A Phase 2 Study Demonstrating the Clinical Activity of Duvelisib in Patients with Relapsed Refractory Indolent Non-Hodgkin Lymphoma

Ian W. Flinn, MD PhD, Carole B. Miller, MD, Kirit M Ardeshna, Scott Tetreault, MD, Sarit E. Assouline, MD MSc, Pier Luigi Zinzani, MD PhD, Jiri Mayer, MD, Michele Merli, MD, Scott D Lunin, MD, Andrew R. Pettitt, Zsolt Nagy, MD PhD, Oliver Tournilhac, MD, Karim Etienne Abou-Nassar, MD, Michael Crump, MD, Eric D. Jacobsen, MD, Sven de Vos, MD PhD, Pedro Santabarbara, MD, Weiliang Shi, PhD, Lori Steelman, MA, Nina D. Wagner-Johnston, MD
Journal: Blood
Blood (2016) 128 (22): 1218.
https://doi.org/10.1182/blood.V128.22.1218.1218
Published: 2016